Log in to save to my catalogue

Phase I trial of combined treatment with chl4.18 and R24 monoclonal antibodies and interleukin-2 for...

Phase I trial of combined treatment with chl4.18 and R24 monoclonal antibodies and interleukin-2 for...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pascalfrancis_primary_17704641

Phase I trial of combined treatment with chl4.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma

About this item

Full title

Phase I trial of combined treatment with chl4.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma

Publisher

Berlin: Springer

Journal title

Cancer immunology and immunotherapy, 2006, Vol.55 (7), p.761-774

Language

English

Formats

Publication information

Publisher

Berlin: Springer

More information

Alternative Titles

Full title

Phase I trial of combined treatment with chl4.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pascalfrancis_primary_17704641

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pascalfrancis_primary_17704641

Other Identifiers

ISSN

0340-7004

How to access this item